Literature DB >> 16534253

Radiosurgery for the treatment of spinal melanoma metastases.

Peter C Gerszten1, Steven A Burton, Annette E Quinn, Sanjiv S Agarwala, John M Kirkwood.   

Abstract

BACKGROUND: The role of stereotactic radiosurgery in treating metastatic melanoma involving the spine has previously been limited. Conventional external beam radiotherapy lacks the precision to allow delivery of large single-fraction doses of radiation and simultaneously to limit the dose delivered to radiosensitive structures such as the spinal cord. This study evaluated the clinical efficacy of radiosurgery for the treatment of melanoma spinal metastases in 28 patients.
METHODS: Thirty-six melanoma spine metastases were treated with a single-session radiosurgery technique (1 cervical, 11 thoracic, 13 lumbar, and 11 sacral) with a follow-up period of 3-43 months (median 13 months). Tumor volume ranged from 4.1 to 153 cm3 (mean 47.6 cm3). Twenty-three of the 36 lesions had received prior external beam irradiation.
RESULTS: Maximum tumor dose was maintained at 17.5-25 Gy (mean 21.7 Gy). Spinal cord volume receiving > 8 Gy ranged from 0.0 to 0.7 cm3 (mean 0.26 cm3); spinal canal volume at the cauda equina level receiving > 8 Gy ranged from 0.0 to 3.5 cm3 (mean 0.98 cm3). No radiation-induced toxicity occurred during the follow-up period. Axial and radicular pain improved in 27 of 28 patients (96%) who were treated primarily for pain. Long-term tumor control was seen in 3 of 4 cases treated primarily for radiographic tumor progression. Two patients went on to require open surgical intervention for tumor progression resulting in neurological deficit.
CONCLUSIONS: Spinal radiosurgery offers a therapeutic modality for the safe delivery of large dose fractions of radiation therapy in a single fraction for the management of spinal metastases in patients with advanced melanoma that are often poorly controlled with alternative conventional external beam radiation therapy, and is successful even in patients with previously irradiated lesions. 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2006        PMID: 16534253     DOI: 10.1159/000091952

Source DB:  PubMed          Journal:  Stereotact Funct Neurosurg        ISSN: 1011-6125            Impact factor:   1.875


  29 in total

1.  The impact of histology and delivered dose on local control of spinal metastases treated with stereotactic radiosurgery.

Authors:  Yoshiya Yamada; Evangelia Katsoulakis; Ilya Laufer; Michael Lovelock; Ori Barzilai; Lily A McLaughlin; Zhigang Zhang; Adam M Schmitt; Daniel S Higginson; Eric Lis; Michael J Zelefsky; James Mechalakos; Mark H Bilsky
Journal:  Neurosurg Focus       Date:  2017-01       Impact factor: 4.047

2.  Radiotherapy for oligometastatic disease in patients with spinal cord compression (MSCC) from relatively radioresistant tumors.

Authors:  Katja Freundt; Thekla Meyners; Amira Bajrovic; Hiba Basic; Johann H Karstens; Irenaeus A Adamietz; Volker Rudat; Steven E Schild; Juergen Dunst; Dirk Rades
Journal:  Strahlenther Onkol       Date:  2010-03-26       Impact factor: 3.621

3.  [Advantages of stereotactic body radiation vs. conventional radiation for spinal metastases].

Authors:  D Rades
Journal:  Strahlenther Onkol       Date:  2013-04       Impact factor: 3.621

Review 4.  Radiation therapy for cutaneous melanoma.

Authors:  Christopher A Barker; Nancy Y Lee
Journal:  Dermatol Clin       Date:  2012-06-07       Impact factor: 3.478

5.  [Value of postoperative stereotaxic body radiation therapy for spinal metastases].

Authors:  Dirk Rades
Journal:  Strahlenther Onkol       Date:  2017-02       Impact factor: 3.621

6.  Spine radiosurgery for spinal cord compression: the radiation oncologist's perspective.

Authors:  William F Regine; Samuel Ryu; Eric L Chang
Journal:  J Radiosurg SBRT       Date:  2011

7.  Prospective validation of treatment accuracy using implanted fiducial markers for spinal stereotactic body radiation therapy.

Authors:  David C Weksberg; James N Yang; Alda L Tam; Jing Li; Xin A Wang; Zhongxiang Zhao; Stephen E McRae; Stephen H Settle; Laurence D Rhines; Eric L Chang; Paul D Brown; Amol J Ghia
Journal:  J Radiosurg SBRT       Date:  2016

8.  Spinal radiosurgery: a neurosurgical perspective.

Authors:  Mark H Bilsky; Lilyana Angelov; Jack Rock; Jason Weaver; Jason Sheehan; Laurence Rhines; Syed Azeem; Peter Gerszten
Journal:  J Radiosurg SBRT       Date:  2011

9.  Downregulation of matrix metalloproteinase-2 (MMP-2) utilizing adenovirus-mediated transfer of small interfering RNA (siRNA) in a novel spinal metastatic melanoma model.

Authors:  Andrew J Tsung; Odysseas Kargiotis; Chandramu Chetty; Sajani S Lakka; Meena Gujrati; Daniel G Spomar; Dzung H Dinh; Jasti S Rao
Journal:  Int J Oncol       Date:  2008-03       Impact factor: 5.650

10.  Local disease control for spinal metastases following "separation surgery" and adjuvant hypofractionated or high-dose single-fraction stereotactic radiosurgery: outcome analysis in 186 patients.

Authors:  Ilya Laufer; J Bryan Iorgulescu; Talia Chapman; Eric Lis; Weiji Shi; Zhigang Zhang; Brett W Cox; Yoshiya Yamada; Mark H Bilsky
Journal:  J Neurosurg Spine       Date:  2013-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.